Celldex Therapeutics Stock Probability of Future Stock Price Finishing Over 6.0
| CLDX Stock | USD 39.63 1.03 2.67% |
Closest to current price Celldex long CALL Option Payoff at Expiration
Celldex |
Celldex Therapeutics Target Price Odds to finish over 6.0
The tendency of Celldex Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 6.00 in 90 days |
| 39.63 | 90 days | 6.00 | close to 99 |
Based on a normal probability distribution, the odds of Celldex Therapeutics to stay above $ 6.00 in 90 days from now is close to 99 (This Celldex Therapeutics probability density function shows the probability of Celldex Stock to fall within a particular range of prices over 90 days) . Probability of Celldex Therapeutics price to stay between $ 6.00 and its current price of $39.63 at the end of the 90-day period is about 37.92 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.13 suggesting Celldex Therapeutics market returns are sensitive to returns on the market. As the market goes up or down, Celldex Therapeutics is expected to follow. Additionally Celldex Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Celldex Therapeutics Price Density |
| Price |
Predictive Modules for Celldex Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Celldex Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Celldex Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Celldex Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Celldex Therapeutics is not an exception. The market had few large corrections towards the Celldex Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Celldex Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Celldex Therapeutics within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.06 | |
β | Beta against NYSE Composite | 1.13 | |
σ | Overall volatility | 4.37 | |
Ir | Information ratio | -0.01 |
Celldex Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Celldex Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Celldex Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Celldex Therapeutics had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 6.88 M. Net Loss for the year was (141.43 M) with loss before overhead, payroll, taxes, and interest of (79.9 M). | |
| Celldex Therapeutics currently holds about 356.82 M in cash with (107.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.63. | |
| Celldex Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from investing.com: Celldex completes patient enrollment for Phase 2 urticaria trial |
Celldex Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Celldex Stock often depends not only on the future outlook of the current and potential Celldex Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Celldex Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.4 M | |
| Cash And Short Term Investments | 421.7 M |
Celldex Therapeutics Technical Analysis
Celldex Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Celldex Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Celldex Therapeutics. In general, you should focus on analyzing Celldex Stock price patterns and their correlations with different microeconomic environments and drivers.
Celldex Therapeutics Predictive Forecast Models
Celldex Therapeutics' time-series forecasting models is one of many Celldex Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Celldex Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Celldex Therapeutics
Checking the ongoing alerts about Celldex Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Celldex Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Celldex Therapeutics had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 6.88 M. Net Loss for the year was (141.43 M) with loss before overhead, payroll, taxes, and interest of (79.9 M). | |
| Celldex Therapeutics currently holds about 356.82 M in cash with (107.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.63. | |
| Celldex Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from investing.com: Celldex completes patient enrollment for Phase 2 urticaria trial |
Check out Celldex Therapeutics Backtesting, Celldex Therapeutics Valuation, Celldex Therapeutics Correlation, Celldex Therapeutics Hype Analysis, Celldex Therapeutics Volatility, Celldex Therapeutics History as well as Celldex Therapeutics Performance. For more information on how to buy Celldex Stock please use our How to Invest in Celldex Therapeutics guide.Note that the Celldex Therapeutics information on this page should be used as a complementary analysis to other Celldex Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Celldex Stock analysis
When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Celldex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celldex Therapeutics. If investors know Celldex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celldex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.92) | Revenue Per Share 0.142 | Quarterly Revenue Growth 1.561 | Return On Assets (0.22) | Return On Equity (0.37) |
The market value of Celldex Therapeutics is measured differently than its book value, which is the value of Celldex that is recorded on the company's balance sheet. Investors also form their own opinion of Celldex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Celldex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celldex Therapeutics' market value can be influenced by many factors that don't directly affect Celldex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celldex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Celldex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celldex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.